MARSICO CAPITAL MANAGEMENT LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSICO CAPITAL MANAGEMENT LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2020$1,290,000
+25.4%
13,255
+58.1%
0.04%
+12.5%
Q2 2020$1,029,000
+32.6%
8,386
-5.3%
0.03%
-3.0%
Q1 2020$776,000
-56.3%
8,857
-47.9%
0.03%
-47.6%
Q4 2019$1,777,000
-75.3%
16,991
-72.8%
0.06%
-77.5%
Q3 2019$7,194,000
-31.6%
62,537
+2.5%
0.28%
-25.3%
Q2 2019$10,514,000
-15.7%
60,990
-17.5%
0.38%
-16.7%
Q1 2019$12,468,000
+72.5%
73,961
-0.3%
0.45%
+47.5%
Q4 2018$7,228,000
-54.6%
74,219
-19.5%
0.30%
-43.3%
Q3 2018$15,924,000
+983.3%
92,187
+473.2%
0.54%
+3486.7%
Q3 2015$1,470,00016,0830.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders